Medical/Scientific informed, articulate news announcer
Description
Vocal Characteristics
Language
EnglishVoice Age
Middle Aged (35-54)Accents
North American (General)Transcript
Note: Transcripts are generated using speech recognition software and may contain errors.
The FDA has given orphan drug status to C. T. 053 an investigational chimeric antigen receptor T cell therapy for the treatment of multiple myeloma. C. T. 053 from Cars gem therapeutics is an autologous, fully human car T cell therapy that targets the B cell maturation antigens on the surface of cancer cells. Cars JAN C T 053 is one of the company's three car T cell products approved for early stage clinical trials. The others include humanized CD 19 car t for B cell leukemia and lymphoma and GPC three CAR T for hepatitis cellular carcinoma and non small cell lung cancer shanghai lee M. D. PhD, founder Ceo and chief scientific officer of Cars Jen said in a press release FDA orphan designation is an important regulatory milestone in the continued development and commercialization of C. T. 053 anti BCM A car T cells.